Familial thoracic aortic aneurysms and dissections

Journal of Forensic Sciences

Volumn 43, Issue 6, 1998, Pages 1244-1249

  Prahlow, Joseph A ^a   Barnard, Jeffrey J ^a   Milewicz, Dianna M ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Aneurysm; Aorta; Autosomal dominant; Dissection; Familial; Forensic pathology; Forensic science; Marfan syndrome

Indexed keywords

ADULT; AORTA ATHEROSCLEROSIS; AORTA DISSECTION; AORTA RUPTURE; ARTERY DILATATION; ARTICLE; CASE REPORT; CORONARY ARTERY ATHEROSCLEROSIS; FAMILIAL DISEASE; HEART TAMPONADE; HEMOPERICARDIUM; HUMAN; MALE; MARFAN SYNDROME; PRIORITY JOURNAL; THORACIC AORTA ANEURYSM; THORAX INJURY;

EID: 0031729880     PISSN: 00221198     EISSN: None     Source Type: Journal    
DOI: 10.1520/jfs14395j     Document Type: Article

References (18)

1. Dietz HC, Pyeritz RE. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Molecular Genet 1995;4:1799-809.
2. Collod G, Babron M-C, Jondeau G, Coulon M, Weissenbach J, Dubourg O, et al. A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nature Genet 1994;8:264-8.
3. Francke U, Berg MA, Tynan K, Brenn T, Liu W, Aoyama T, et al. A Gly 1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. Am J Hum Genet 1995;56:1287-96.
4. DiMaio DJ, DiMaio VJM. Forensic Pathology. Boca Raton, FL: CRC Press, Inc. 1993.
5. Wilson SK, Hutchins GM. Aortic dissecting aneurysms - causative factors in 204 subjects. Arch Pathol Lab Med 1982;106:175-80.
6. Backerstaff LK, Pairolero PC, Hollier LH, Melton LJ, Van Peenen HJ, Cherry KJ, et al. Thoracic aortic aneurysms: a population-based study. Surgery 1982;1103-8.
7. Pressler V, McNamara JJ. Thoracic aortic aneurysm - natural history and treatment. J Thorac Cardiovasc Surg 1980;79:489-98.
8. Spittell JA. Hypertension and arterial aneurysm. J Am Coll Cardiol 1983;1:533-40.
9. Schoen FJ. Blood vessels. In Cotran RS, Kumar V, Robbins SL, editors. Robbins pathologic basis of disease. 5th ed. Philadelphia: W.B. Saunders Company. 1994;467-516.
10. Ramirez F. Fibrillin mutations in Marfan syndrome and related phenotypes. Curr Opin Genet Develop 1996;6:309-15.
11. DePaepe A, Devereux RB, Dietz HC, Hennekam RCM, Pyeritz RE. Raised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996;62:417-26.
12. Mellion MB. Diagnosing Marfan syndrome. Heart Dis Stroke 1994; 3:241-5.
13. Milewicz DM, Michael K, Fisher N, Coselli JS, Markello T, Biddinger A. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation 1996;94:2708-11.
14. Putnam EA, Zhang H, Ramirez F, Milewicz DM. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly (letter). Nature Genet 1995;11:456-8.
15. Biddinger A, Rocklin M, Coselli J, Milewicz DM. Familial thoracic aortic dilatations and dissections: a case control study. J Vasc Surg 1997;25:506-11.
16. Harada H, Ichimiya Y, Kamata K, Kazui T, Komatsu S. Three cases of familial dissecting aortic aneurysm. J Japan Assoc Thorac Surg 1990;38:1497-500.
17. Nicod P, Bloor C, Godfrey M, Hollister D, Pyeritz RE, Dittrich H, et al. Familial aortic dissecting aneurysm. J Am Coll Cardiol 1989; 13:811-9.
18. Milewicz DM, Park E-S, Petty EM, Zaghi H, Pai S, Willing M, et al. Clinical features and generic heterogeneity of familial thoracic aortic aneurysms/dissections. Am J. Cardiol 1998; In Press.